Bank of America’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83K | Buy |
24,625
+2,459
| +11% | +$8.29K | ﹤0.01% | 5624 |
|
|
2025
Q1 | $85.6K | Sell |
22,166
-12,994
| -37% | -$50.2K | ﹤0.01% | 5568 |
|
|
2024
Q4 | $217K | Sell |
35,160
-1,651
| -4% | -$10.2K | ﹤0.01% | 5215 |
|
|
2024
Q3 | $198K | Buy |
36,811
+4,527
| +14% | +$24.4K | ﹤0.01% | 5149 |
|
|
2024
Q2 | $108K | Sell |
32,284
-13,113
| -29% | -$43.9K | ﹤0.01% | 5398 |
|
|
2024
Q1 | $183K | Sell |
45,397
-40,941
| -47% | -$165K | ﹤0.01% | 5091 |
|
|
2023
Q4 | $229K | Buy |
86,338
+37,603
| +77% | +$99.6K | ﹤0.01% | 5099 |
|
|
2023
Q3 | $115K | Sell |
48,735
-29,143
| -37% | -$68.8K | ﹤0.01% | 5319 |
|
|
2023
Q2 | $491K | Buy |
77,878
+21,635
| +38% | +$136K | ﹤0.01% | 4497 |
|
|
2023
Q1 | $325K | Sell |
56,243
-239,617
| -81% | -$1.38M | ﹤0.01% | 4887 |
|
|
2022
Q4 | $3.04M | Buy |
295,860
+228,971
| +342% | +$2.35M | ﹤0.01% | 3333 |
|
|
2022
Q3 | $1.12M | Buy |
66,889
+38,914
| +139% | +$650K | ﹤0.01% | 4116 |
|
|
2022
Q2 | $391K | Sell |
27,975
-29,224
| -51% | -$408K | ﹤0.01% | 4888 |
|
|
2022
Q1 | $924K | Buy |
57,199
+2,262
| +4% | +$36.5K | ﹤0.01% | 4683 |
|
|
2021
Q4 | $1.18M | Buy |
54,937
+23,307
| +74% | +$499K | ﹤0.01% | 4377 |
|
|
2021
Q3 | $465K | Buy |
31,630
+25,228
| +394% | +$371K | ﹤0.01% | 4909 |
|
|
2021
Q2 | $127K | Sell |
6,402
-15,219
| -70% | -$302K | ﹤0.01% | 5600 |
|
|
2021
Q1 | $646K | Buy |
+21,621
| New | +$646K | ﹤0.01% | 4575 |
|